Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1537PDF: 875HTML: 973figures: 177table 1: 180table2: 178table3: 179 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4760PDF: 1757HTML: 2701Untitled: 211 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3868Suppl. Files: 1098PDF: 1060Html: 170 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3234PDF: 1230HTML: 8100 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
829PDF: 486HTML: 1300 -
HEPATITIS B AND C IN HEMATOPOIETIC STEM CELL TRANSPLANT
961PDF: 530HTML: 720 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3664PDF: 1231HTML: 3876Untitled: 206Untitled: 256 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3731PDF: 1465HTML: 478Figures . Eliassian: 216 -
IMMUNOLOGY OF TUBERCULOSIS
5242PDF: 1995HTML: 7288Untitled: 195 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10532PDF: 6329HTML: 21778 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
926PDF: 567HTML: 2185Cover Letter: 189 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3266PDF: 1336HTML: 2619 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1918PDF: 1156HTML: 265 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1373PDF: 814HTML: 3115 -
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4074PDF: 1576HTML: 928 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1155PDF: 600HTML: 6793 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1363PDF: 1300HTML: 92 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3281PDF: 1308HTML: 6185 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3007PDF: 1021HTML: 3071 -
-
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1277PDF: 1007HTML: 115 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
6897PDF: 3897HTML: 24869







